Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Organophosphorus Poisoning
Interventions
DRUG

Pralidoxime

Inj. Pralidoxime 1 gm I/V will be given as first dose over 10-20 minutes. If no improvement of muscle weakness, then repeat the dose after one hour. Then 1 gram of Inj. Pralidoxime will be given at an 8-hour interval

DRUG

Atropine

Inj. Atropine (3 ampule) will be given in intravenous route as a first dose, rapidly. Then the dose will be doubled from the previous dose in every 5 minutes interval until the signs of atropinisation appeared. Then infusion of 10% of the total bolus dose (the dose that was given until the signs of atropinisation appeared) per hour, will be given with intravenous Normal saline/ 5% DNS(Dextrose and Sodium chloride) as a maintenance dose. The dose will be reduced for adjustment, based on clinical features/improvement

Trial Locations (1)

1100

Sir Salimullah Medical College Mitford Hospital, Dhaka

All Listed Sponsors
lead

Sir Salimullah Medical College Mitford Hospital

OTHER_GOV